(Q40784670)

23 September 2017

title

Neuropharmacology and therapeutic potential of cannabinoids (English)

1 reference

23 September 2017

0 references

R G Pertwee

1

1 reference

23 September 2017

publication date

1 January 2000

1 reference

23 September 2017

1 reference

23 September 2017

volume

5

1 reference

23 September 2017

issue

1

1 reference

23 September 2017

page(s)

37-46

1 reference

The central neuropharmacology of psychotropic cannabinoids

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Cannabinoids decrease acetylcholine release in the medial-prefrontal cortex and hippocampus, reversal by SR 141716A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Occlusion of the presynaptic action of cannabinoids in rat substantia nigra pars reticulata by cadmium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

The cannabinoid agonist Win55,212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Molecular characterization of human and mouse fatty acid amide hydrolases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Fatty acid amide hydrolase, the degradative enzyme for anandamide and oleamide, has selective distribution in neurons within the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Functional role of high-affinity anandamide transport, as revealed by selective inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

(-)-Delta9-tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

delta 9-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Control of pain initiation by endogenous cannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Appetite suppression and weight loss after the cannabinoid antagonist SR 141716.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Suppression of neuropathic pain behavior in rats by a non-psychotropic synthetic cannabinoid with NMDA receptor-blocking properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

The non-psychotropic cannabinoid (+)-(3S,4S)-7-hydroxy-Δ6-tetrahydrocannabinol 1,1-dimethylheptyl (HU-211) attenuates receptor-mediated neurotoxicity in primary cultures of rat forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

A nonpsychotropic cannabinoid, HU-211, has cerebroprotective effects after closed head injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

A novel nonpsychotropic cannabinoid, HU-211, in the treatment of experimental pneumococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Blockade of 45Ca2+ influx through the N-methyl-D-aspartate receptor ion channel by the non-psychoactive cannabinoid HU-211.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Effects of SR 141716A after acute or chronic cannabinoid administration in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Antimicrobial and respiratory burst characteristics of pulmonary alveolar macrophages recovered from smokers of marijuana alone, smokers of tobacco alone, smokers of marijuana and tobacco, and nonsmokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Agonist-antagonist characterization of 6'-cyanohex-2'-yne-delta 8-tetrahydrocannabinol in two isolated tissue preparations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Spinal mechanisms of delta 9-tetrahydrocannabinol-induced analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

(+)-WIN 55,212-2, a novel cannabinoid receptor agonist, exerts antidystonic effects in mutant dystonic hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Evidence for the presence of CB1 cannabinoid receptors on peripheral neurones and for the existence of neuronal non-CB1 cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Neurobehavioral actions of cannabichromene and interactions with Δ9-tetrahydrocannabinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Cannabidiol interferes with the effects of Δ9-tetrahydrocannabinol in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Bronchodilator effect of delta1-tetrahydrocannabinol administered by aerosol of asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556210071252

21 January 2018

Identifiers

DOI

10.1080/13556210071252

1 reference

23 September 2017

1 reference